• 1. Iminium and enamine catalysis in enantioselective photochemical reactions
  You-Quan Zou,Fabian M. H?rmann,Thorsten Bach Chem. Soc. Rev. 2018 47 278
• 2. Recent advances in the direct construction of enantioenriched stereocenters through addition of radicals to internal alkenes
  Tao Xiong,Qian Zhang Chem. Soc. Rev. 2021 50 8857

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Introduction to 2-(4-Fluorophenyl)-4-methylpyridine (CAS No. 222551-24-8)

2-(4-Fluorophenyl)-4-methylpyridine, identified by the Chemical Abstracts Service Number (CAS No.) 222551-24-8, is a significant compound in the realm of pharmaceutical and chemical research. This heterocyclic aromatic amine features a pyridine core substituted with a 4-fluorophenyl group and a methyl group at the 4-position. Its unique structural attributes make it a valuable intermediate in the synthesis of various bioactive molecules, particularly in drug discovery and development.

The presence of a fluorine atom at the para position of the phenyl ring introduces unique electronic and steric properties, which can influence the compound's reactivity, solubility, and metabolic stability. This feature is particularly exploited in medicinal chemistry, where fluorinated aromatic compounds are known to enhance binding affinity and reduce susceptibility to enzymatic degradation. The methylpyridine moiety further contributes to the compound's versatility, allowing for further functionalization and diversification of its pharmacological profile.

In recent years, 2-(4-fluorophenyl)-4-methylpyridine has garnered attention in academic and industrial research due to its potential applications in the development of novel therapeutic agents. Its structural framework is conducive to serving as a scaffold for small-molecule drugs targeting various diseases, including neurological disorders, cancer, and infectious diseases. The compound's ability to undergo selective modifications at multiple positions makes it an attractive candidate for structure-activity relationship (SAR) studies.

One of the most compelling aspects of 2-(4-fluorophenyl)-4-methylpyridine is its role in the synthesis of kinase inhibitors, which are critical in oncology research. Kinases play a pivotal role in cell signaling pathways, and their dysregulation is often associated with abnormal cell growth and proliferation. By incorporating this compound into drug candidates, researchers aim to develop selective kinase inhibitors that can modulate these pathways effectively. The fluorophenyl group enhances interactions with the enzyme's active site, while the methylpyridine moiety provides steric hindrance to minimize off-target effects.

Furthermore, studies have explored the use of 2-(4-fluorophenyl)-4-methylpyridine as a precursor in the synthesis of antiviral agents. The structural motif is believed to interact with viral proteases and polymerases, inhibiting their activity and thereby reducing viral replication. Preliminary findings suggest that derivatives of this compound exhibit promising antiviral properties against certain RNA viruses. These findings underscore the importance of fluorinated pyridines in developing next-generation antiviral therapeutics.

The compound's chemical properties also make it suitable for applications in material science and agrochemicals. For instance, its ability to form stable complexes with metal ions has been explored in catalytic systems. Additionally, fluorinated pyridines are increasingly used in agrochemical formulations due to their enhanced stability under environmental conditions, contributing to more effective crop protection agents.

Recent advancements in synthetic methodologies have further expanded the utility of 2-(4-fluorophenyl)-4-methylpyridine. Transition-metal-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, have enabled efficient introduction of diverse functional groups onto its core structure. These techniques have facilitated the rapid generation of libraries of derivatives for high-throughput screening (HTS), accelerating drug discovery efforts.

The pharmacokinetic profile of 2-(4-fluorophenyl)-4-methylpyridine and its derivatives is another area of active investigation. Researchers are focusing on optimizing bioavailability by modulating lipophilicity and metabolic stability. Computational modeling techniques, such as molecular dynamics simulations and quantum mechanics calculations, are being employed to predict how structural changes will impact pharmacokinetic properties.

In conclusion, 2-(4-fluorophenyl)-4-methylpyridine (CAS No. 222551-24-8) represents a versatile and valuable building block in modern chemical biology and pharmaceutical research. Its unique structural features offer opportunities for designing novel therapeutic agents with improved efficacy and reduced side effects. As research continues to uncover new applications for this compound, its significance in advancing scientific understanding and therapeutic innovation is likely to grow.

• 58861-53-3(2-(4-Fluorophenyl)pyridine)
• 512171-81-2(5-Fluoro-2-phenylpyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)